Bronte Capital Management’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
CCM
PFCS
GCGM
DMC
MC
MCM
Bronte Capital Management's GUTS Position: Q2 2026 in Review
Bronte Capital Management sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 16,905 shares — an estimated $7.74K sold.
Bronte Capital Management first reported a position in GUTS in Q4 2025 and held it in 2 quarters. The position peaked at $37.2K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.
- Bronte Capital Management reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
- Bronte Capital Management sold 16,905 Fractyl Health shares in Q2 2026, an estimated $7.74K.
- Bronte Capital Management first reported a position in Fractyl Health in Q4 2025 and held it in 2 quarters.
- Bronte Capital Management's Fractyl Health position peaked at $37.2K in Q4 2025.
- 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.
Based on Bronte Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.